Figure 5. SOX2 and OCT4 synergistically regulate C9ORF135 expression in hESCs.
(a) Chromatin immunoprecipitation (ChIP) analysis was conducted using SOX2 and OCT4 antibodies and C9ORF135-specific primers. (b) C9ORF135 promoter activity in the presence or absence of OCT4 and SOX2. (c) OCT4, NANOG, and SOX2 expression analysis in differentiated H1 hESCs. (d) C9ORF135 expression analysis in H1, H9, and LiY ESCs differentiated with retinoic acid (RA) for 7 days. The result shown is the average of triplicate experiments.